Table 1

Reports of studies on chemotherapy during the last 30 days of life (DOL)

% Receiving chemotherapy during
StudyPatients, NType of cancerInclusion criteriaLast 30 DOLLast 14 DOL
Rautakorpi et al2538 982AllAny167.2
Falchook et al3212 765LungPatients<65 years12.6
Ersek et al42847NSCLCAny30.6
Wright et al141146AllAny6.5
Bekelman et al49389 073AllUSA10.6
The Netherlands10.6
Belgium12.7
Canada8.8
UKNR
Germany10.5
Norway4.8
Sano and Fushimi4526 012AllPalliative care consultation1.7
SOC4.0
Parekh et al51242NSCLC2009–10 Prepalliative care17.0
2003–14 Postpalliative care7.0
Pacetti et al392164AllAny24.3
Wang et al5282 242All20054.4
20094.0
Choi et al30263All200214.03.5
201242.723.8
Cheung et al31107 253AllAny3.6
Lee et al382345All200025.7
200532.7
201044.2
Kok et al27266NSCLC2008–20095.0
2011–20121.0
Zhang et al63118NSCLCAny27
Adam et al33120AllAny11.77.6
Sesé et al3594LungAny5522
Amano et al58266AllEarly palliative care17
SOC23
Greer et al29151NSCLCSOC43.323.9
Early palliative care30.013.6
Mack et al461231NSCLC and colorectalAny16.0
Näppä et al40374AllAny23
Gonsalves et al44200All20025
200818
Ho et al37227 161All19932.02
20032.9
Andreis et al59102AllAny166
Warren et al5321 633AllPatients with OS <6 months14.89
Patients with OS >6 months10.26.4
Keating et al475826NSCLC and colorectalVHA cohort4.6
SEER cohort7.5
Kao et al62747AllAny188.0
Hashimoto et al55255AllAny12.63.10
Tang et al28242 530AllTrend 2000–200616.2
Barbera et al345855AllAny4.6
Earle et al11215 484All19939.70
199911.6
Temel et al3646NSCLCIntegrated palliative care4023
Yun et al543750AllAny30.922.5
Murillo and Koeller41417NSCLCAny4320.0
Earle et al1628 777All199313.8
199618.5
Giorgi et al57193AllAny33
Emanuel et al487919AllMassachusetts9
California9
Aragon-Ching etal56144AllAny26
  • NR, not reported; NSCLC, non-small cell lung cancer; SEER, Surveillance, Epidemiology and End Results; SOC, standard of care; VHA, Veterans Health Administration.